ANKRD33 | Ankyrin repeat domain 33 | | | | | | Tissue enriched |
ERVW-1 | Endogenous retrovirus group W, member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted secreted proteins
| | | | | Tissue enriched |
EGFL6 | EGF-like-domain, multiple 6 | Predicted secreted proteins
| | | | | Tissue enriched |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
C4orf26 | Chromosome 4 open reading frame 26 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
GH1 | Growth hormone 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AC096582.1 | Uncharacterized protein | | | | | | Tissue enriched |
IL1RL1 | Interleukin 1 receptor-like 1 | Candidate cardiovascular disease genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
LIN28B | Lin-28 homolog B (C. elegans) | | | | | | Tissue enriched |
TAC3 | Tachykinin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CHAT | Choline O-acetyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
GNGT1 | Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 | RAS pathway related proteins
| | | | | Tissue enriched |
HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
MAGEA8 | Melanoma antigen family A, 8 | | | | | | Tissue enriched |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
EBI3 | Epstein-Barr virus induced 3 | Predicted secreted proteins
| | | | | Tissue enriched |
GPR32 | G protein-coupled receptor 32 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
SLC13A4 | Solute carrier family 13 (sodium/sulfate symporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
VGLL1 | Vestigial like 1 (Drosophila) | | | | | | Tissue enriched |
AC079341.1 | Uncharacterized protein | | | | | | Tissue enriched |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
IGF2 | Insulin-like growth factor 2 (somatomedin A) | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PRG2 | Proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CAPN6 | Calpain 6 | Cancer-related genes Enzymes
| | | | | Tissue enriched |
DLX4 | Distal-less homeobox 4 | Transcription factors
| | | | | Tissue enriched |
EPYC | Epiphycan | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GPC3 | Glypican 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
MEST | Mesoderm specific transcript | Predicted secreted proteins
| | | | | Tissue enriched |
PAGE4 | P antigen family, member 4 (prostate associated) | Cancer-related genes
| | | | | Tissue enriched |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
MAGEA10 | Melanoma antigen family A, 10 | | | | | | Tissue enriched |